US 10548987
Antibody-drug conjugates for targeting CD56-positive tumors
granted A61KA61K2039/507A61K47/68035
Quick answer
US patent 10548987 (Antibody-drug conjugates for targeting CD56-positive tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/507, A61K47/68035, A61K47/6849, A61K47/6851